End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
1,718
KRW
|
+1.72%
|
|
+5.08%
|
-21.01%
|
2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
| 2023 |
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
|
CI
|
|
2024-04-24
|
2024-04-25
|
2024-04-26
|
2024-04-29
|
2024-04-30
|
Last |
1669 ₩
|
1679 ₩
|
1684 ₩
|
1689 ₩
|
1718 ₩
|
Volume |
211 586 |
130 727 |
153 667 |
106 839 |
235 370 |
Change |
+0.72%
|
+0.60%
|
+0.30%
|
+0.30%
|
+1.72%
|
Opening |
1,680.00 |
1,669.00 |
1,679.00 |
1,684.00 |
1,697.00 |
High |
1,680.00 |
1,679.00 |
1,691.00 |
1,697.00 |
1,722.00 |
Low |
1,655.00 |
1,651.00 |
1,668.00 |
1,684.00 |
1,683.00 |
Avg. Volume 20 sessions
226 672
Avg. Volume 20 sessions KRW
389 422 496.00
Avg. Volume 20 sessions USD
281 163.04
Record volume 1
84 880 220
Record volume 2
74 058 590
Record volume 3
57 523 550
Capital turnover ratio
0.00
Capitalization (KRW)
161 820 357 341
Capitalization (USD)
116 834 298
Net sales (KRW)
46 483 649 020
Net sales (USD)
33 561 195
Sales / Employee (KRW)
193 681 871
Sales / Employee (USD)
139 838
Free-Float capitalization (KRW)
144 863 253 361
Free-Float capitalization (USD)
104 591 269
Average Daily Capital Traded
0.24%
Moving average 5 days
1 687.80
Moving average 20 days
1 688.35
Moving average 50 days
1 827.34
Moving average 100 days
2 013.17
Price spread / (MMA5) -1.76% Price spread / (MMA20) -1.73% Price spread / (MMA50) +6.36% Price spread / (MMA100) +17.18%
More charts
|